One of the most criminal aspects of the COVID regime was the decision to pressure low-risk teens into getting a shot that was known to cause cardiac inflammation. Myocarditis used to be a rare disorder discussed mainly in academic literature, but now it is everywhere. What have we done to a generation of young hearts, and what is being done to detect, diagnose, and treat the problem? Unless we can find an angle that ties in to Ukraine, our politicians, media, and medical establishment don’t care.
We are over a year into the known safety signals of this vaccine for myocarditis, and yet the shots still have not been pulled, even for younger males. In fact, it’s still a requirement in many colleges. Yet reports of myocarditis and pericarditis are so prevalent now that just in the first eight weeks of 2022, we’re already at 47% of the total VAERS submissions for 2021. There were 24,177 reports of pericarditis/myocarditis submitted to VAERS in 2021. In 2022, just through Feb. 25, there were 11,289 reports, which is nearly half of last year’s total. Here is the graphic presentation from Open VAERS:
(bigger)
The reporting to VAERS is very disturbing because the trend line of vaccination, especially for the younger people more prone to this heart inflammation, has halted to a trickle in recent weeks. So why are there so many more reports this year? There are likely two possible explanations. Either more people and doctors know about VAERS and know to look for myocarditis, or there is a time bomb with many more people now realizing they have heart problems months later. Either way, this means that the initial estimates of case prevalence were just the tip of the iceberg, and we are likely to see young hearts damaged for years to come.
What is so shocking is that several weeks ago, the CDC recognized the problem and attempted to get ahead of it by suggesting that “an 8-week interval may be optimal for some people ages 12 years and older, especially for males ages 12 to 39 years.” But historically, if we recognized even a fraction of heart problems from a shot, it would have been pulled from the market entirely! Yet here they are still recommending it, despite the fact that the virus poses low risk for this age group, notwithstanding the fact that the shot doesn’t stop transmission and that it is now outdated for the current strain of the virus!
If the reporting of myocarditis and pericarditis continues at this rate, we’ll see over 73,000 cases this year. And even if more people have become aware of VAERS, it is still woefully underreported.
Read the rest here.
